cik stringclasses 1
value | date stringlengths 8 8 | form stringclasses 4
values | sentenceCount int64 0 2.33k | sentence stringlengths 2 5.25k | filename stringlengths 40 40 |
|---|---|---|---|---|---|
0000320193 | 20141027 | 10-K | 1,026 | In accordance with the fair value accounting requirements, companies may choose to measure eligible financial instruments and certain other items at fair value. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,027 | The Company has not elected the fair value option for any eligible financial instruments. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,028 | Apple Inc. | 2014 Form 10-K | 55
Foreign Currency Translation and Remeasurement
The Company translates the assets and liabilities of its non-U.S. dollar functional currency subsidiaries into U.S. dollars using exchange rates in effect at the end of each period. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,029 | Revenue and expenses for these subsidiaries are translated using rates that approximate those in effect during the period. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,030 | Gains and losses from these translations are recognized in foreign currency translation included in AOCI in shareholders’ equity. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,031 | The Company’s subsidiaries that use the U.S. dollar as their functional currency remeasure monetary assets and liabilities at exchange rates in effect at the end of each period, and inventories, property and nonmonetary assets and liabilities at historical rates. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,032 | Gains and losses from these remeasurements were not significant during 2014, 2013 and 2012 and have been included in the Company’s results of operations. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,033 | Note 2 - Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables show the Company’s cash and available-for-sale securities’ adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short-... | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,034 | The net realized gains or losses recognized by the Company, related to such sales, were not significant during 2014, 2013 and 2012. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,035 | The maturities of the Company’s long-term marketable securities generally range from one to five years. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,036 | As of September 27, 2014 and September 28, 2013, gross unrealized losses related to individual securities that had been in a continuous loss position for 12 months or longer were not significant. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,037 | As of September 27, 2014, the Company considers the declines in market value of its marketable securities investment portfolio to be temporary in nature and does not consider any of its investments other-than-temporarily impaired. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,038 | The Company typically invests in highly-rated securities, and its investment policy limits the amount of credit exposure to any one issuer. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,039 | The policy generally requires investments to be investment grade, with the primary objective of minimizing the potential risk of principal loss. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,040 | Fair values were determined for each individual security in the investment portfolio. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,041 | When evaluating an investment for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes in market interest rates, and the Company’s intent to sell, or wh... | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,042 | During 2014, 2013 and 2012 the Company did not recognize any significant impairment charges. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,043 | Apple Inc. | 2014 Form 10-K | 57
Derivative Financial Instruments
The Company uses derivatives to partially offset its business exposure to foreign currency and interest rate risk. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,044 | The Company may enter into forward contracts, option contracts, swaps, or other derivative instruments to offset some of the risk on expected future cash flows, on net investments in certain foreign subsidiaries and on certain existing assets and liabilities. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,045 | However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,046 | There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,047 | To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company’s subsidiaries whose functional currency is the U.S. dollar hedge a portion of forecasted foreign currency revenue. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,048 | The Company’s subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries’ functional currencies. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,049 | The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,050 | To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,051 | The Company may also enter into foreign currency forward contracts and option contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,052 | The Company may enter into interest rate swaps, options, or other instruments to manage interest rate risk. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,053 | These instruments may offset a portion of changes in income or expense, or changes in fair value of the Company’s long-term debt or investments. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,054 | The Company records all derivatives in the Consolidated Balance Sheets at fair value. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,055 | The Company’s accounting treatment for these instruments is based on the hedge designation. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,056 | The effective portions of cash flow hedges are recorded in AOCI until the hedged item is recognized in earnings. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,057 | Gains and losses related to changes in fair value hedges are recognized in earnings along with a corresponding loss or gain related to the change in value of the underlying hedged item. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,058 | The effective portions of net investment hedges are recorded in other comprehensive income (“OCI”) as a part of the cumulative translation adjustment. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,059 | The ineffective portions of cash flow hedges and net investment hedges are recorded in other income and expense. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,060 | Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,061 | Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in th... | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,062 | Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized as a component of other income/(expense), net in the same period as the related income or expense is recognized. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,063 | The Company’s foreign currency and interest rate transactions hedged with cash flow hedges as of September 27, 2014 are expected to occur within 12 months and four years, respectively. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,064 | Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,065 | Deferred gains and losses in AOCI associated with such derivative instruments are reclassified immediately into other income and expense. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,066 | Any subsequent changes in fair value of such derivative instruments are reflected in other income and expense unless they are re-designated as hedges of other transactions. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,067 | The Company did not recognize any significant net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during 2014, 2013 and 2012. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,068 | The gain/loss recognized in other income and expense for foreign currency forward and option contracts not designated as hedging instruments was not significant during 2014, 2013 and 2012. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,069 | These amounts represent the net gain or loss on the derivative contracts and do not include changes in the related exposures, which generally offset a portion of the gain or loss on the derivative contracts. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,070 | Apple Inc. | 2014 Form 10-K | 58
The following table shows the notional amounts of the Company’s outstanding derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of September 27, 2014 and September 28, 2013 (in millions):
The notional amounts for outstanding ... | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,071 | The credit risk amounts represent the Company’s gross exposure to potential accounting loss on derivative instruments that are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency or interest rates at each respective date. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,072 | The Company’s gross exposure on these transactions may be further mitigated by collateral received from certain counterparties. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,073 | The Company’s exposure to credit loss and market risk will vary over time as currency and interest rates change. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,074 | Although the table above reflects the notional and credit risk amounts of the Company’s derivative instruments, it does not reflect the gains or losses associated with the exposures and transactions that the instruments are intended to hedge. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,075 | The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,076 | The Company generally enters into master netting arrangements, which are designed to reduce credit risk by permitting net settlement of transactions with the same counterparty. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,077 | To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net fair value of certain financial instruments fluctuates from contractually established thresholds. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,078 | The Company presents its derivative assets and derivative liabilities at their gross fair values in its Consolidated Balance Sheets. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,079 | As of September 27, 2014, the Company received $2.1 billion of cash collateral related to the derivative instruments under its collateral security arrangements, which were recorded as accrued expenses in the Consolidated Balance Sheet. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,080 | As of September 28, 2013, the Company posted cash collateral related to the derivative instruments under its collateral security arrangements of $164 million, which were recorded as other current assets in the Consolidated Balance Sheet. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,081 | The Company did not have any derivative instruments with credit-risk related contingent features that would require it to post additional collateral as of September 27, 2014 or September 28, 2013. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,082 | Under master netting arrangements with the respective counterparties to the Company’s derivative contracts, the Company is allowed to net settle transactions with a single net amount payable by one party to the other. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,083 | As of September 27, 2014 and September 28, 2013, the potential effects of these rights of set-off associated with the Company’s derivative contracts, including the effects of collateral, would be a reduction to both derivative assets and derivative liabilities of $1.6 billion and $333 million, respectively, resulting i... | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,084 | Apple Inc. | 2014 Form 10-K | 59
The following tables show the Company’s derivative instruments at gross fair value as reflected in the Consolidated Balance Sheets as of September 27, 2014 and September 28, 2013 (in millions):
(1) The fair value of derivative assets is measured using Level 2 fair value inputs and is re... | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,085 | (2) The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Consolidated Balance Sheets. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,086 | The following tables show the pre-tax effect of the Company’s derivative instruments designated as cash flow, net investment and fair value hedges on OCI and the Consolidated Statements of Operations for 2014, 2013 and 2012 (in millions):
The Company recognized a charge of $120 million, $301 million and $658 million in... | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,087 | The ineffective portions of and amounts excluded from the effectiveness testing of net investment and fair value hedges recognized in other income and expense were not significant during 2014, 2013 and 2012. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,088 | Apple Inc. | 2014 Form 10-K | 60
Accounts Receivable
Trade Receivables
The Company has considerable trade receivables outstanding with its third-party cellular network carriers, wholesalers, retailers, value-added resellers, small and mid-sized businesses, and education, enterprise and government customers. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,089 | The Company generally does not require collateral from its customers; however, the Company will require collateral in certain instances to limit credit risk. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,090 | In addition, when possible, the Company attempts to limit credit risk on trade receivables with credit insurance for certain customers or by requiring third-party financing, loans or leases to support credit exposure. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,091 | These credit-financing arrangements are directly between the third-party financing company and the end customer. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,092 | As such, the Company generally does not assume any recourse or credit risk sharing related to any of these arrangements. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,093 | As of September 27, 2014, the Company had two customers that represented 10% or more of total trade receivables, one of which accounted for 16% and the other 13%. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,094 | As of September 28, 2013, the Company had two customers that represented 10% or more of total trade receivables, one of which accounted for 13% and the other 10%. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,095 | The Company’s cellular network carriers accounted for 72% and 68% of trade receivables as of September 27, 2014 and September 28, 2013, respectively. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,096 | The additions and write-offs to the Company’s allowance for doubtful accounts during 2014, 2013 and 2012 were not significant. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,097 | Vendor Non-Trade Receivables
The Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these manufacturing vendors who manufacture sub-assemblies or assemble final products for the Company. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,098 | The Company purchases these components directly from suppliers. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,099 | Three of the Company’s vendors accounted for 51%, 16% and 14% of total vendor non-trade receivables as of September 27, 2014 and three of the Company’s vendors accounted for 47%, 21% and 15% of total vendor non-trade receivables as of September 28, 2013. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,100 | The Company does not reflect the sale of these components in net sales and does not recognize any profits on these sales until the related products are sold by the Company, at which time any profit is recognized as a reduction of cost of sales. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,101 | Note 3 - Consolidated Financial Statement Details
The following tables show the Company’s consolidated balance sheet details as of September 27, 2014 and September 28, 2013 (in millions):
Inventories
Property, Plant and Equipment
Apple Inc. | 2014 Form 10-K | 61
Accrued Expenses
Non-Current Liabilities
Other Income and... | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,102 | The total purchase price consideration for these acquisitions was $2.6 billion, which consisted primarily of cash, of which $2.2 billion was allocated to goodwill, $636 million to acquired intangible assets and $258 million to net liabilities assumed. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,103 | Concurrent with the close of the acquisition, the Company repaid $295 million of existing Beats outstanding debt to third-party creditors. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,104 | In conjunction with the Beats acquisitions, the Company issued approximately 5.1 million shares of its common stock to certain former equity holders of Beats. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,105 | The restricted stock was valued at approximately $485 million based on the Company’s common stock on the acquisition date. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,106 | The majority of these shares, valued at approximately $417 million, will vest over time based on continued employment with Apple. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,107 | The Company also completed various other business acquisitions during 2014 for an aggregate cash consideration, net of cash acquired, of $957 million, of which $828 million was allocated to goodwill, $257 million to acquired intangible assets and $128 million to net liabilities assumed. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,108 | The Company completed various business acquisitions during 2013 for an aggregate cash consideration, net of cash acquired, of $496 million, of which $419 million was allocated to goodwill, $179 million to acquired intangible assets and $102 million to net liabilities assumed. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,109 | The Company’s gross carrying amount of goodwill was $4.6 billion and $1.6 billion as of September 27, 2014 and September 28, 2013, respectively. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,110 | The Company did not have any goodwill impairments during 2014, 2013 or 2012. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,111 | Apple Inc. | 2014 Form 10-K | 62
The following table summarizes the components of gross and net intangible asset balances as of September 27, 2014 and September 28, 2013 (in millions):
Amortization expense related to acquired intangible assets was $1.1 billion, $960 million and $605 million in 2014, 2013 and 2012, resp... | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,112 | As of September 27, 2014, the remaining weighted-average amortization period for acquired intangible assets is 3.8 years. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,113 | The expected annual amortization expense related to acquired intangible assets as of September 27, 2014, is as follows (in millions):
Note 5 - Income Taxes
The provision for income taxes for 2014, 2013 and 2012, consisted of the following (in millions):
Apple Inc. | 2014 Form 10-K | 63
The foreign provision for income ... | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,114 | The Company’s consolidated financial statements provide for any related tax liability on undistributed earnings that the Company does not intend to be indefinitely reinvested outside the U.S. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,115 | Substantially all of the Company’s undistributed international earnings intended to be indefinitely reinvested in operations outside the U.S. were generated by subsidiaries organized in Ireland, which has a statutory tax rate of 12.5%. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,116 | As of September 27, 2014, U.S. income taxes have not been provided on a cumulative total of $69.7 billion of such earnings. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,117 | The amount of unrecognized deferred tax liability related to these temporary differences is estimated to be approximately $23.3 billion. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,118 | As of September 27, 2014 and September 28, 2013, $137.1 billion and $111.3 billion, respectively, of the Company’s cash, cash equivalents and marketable securities were held by foreign subsidiaries and are generally based in U.S. dollar-denominated holdings. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,119 | Amounts held by foreign subsidiaries are generally subject to U.S. income taxation on repatriation to the U.S.
A reconciliation of the provision for income taxes, with the amount computed by applying the statutory federal income tax rate (35% in 2014, 2013 and 2012) to income before provision for income taxes for 2014,... | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,120 | For stock options, the Company receives an income tax benefit calculated as the tax effect of the difference between the fair market value of the stock issued at the time of the exercise and the exercise price. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,121 | For RSUs, the Company receives an income tax benefit upon the award’s vesting equal to the tax effect of the underlying stock’s fair market value. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,122 | The Company had net excess tax benefits from equity awards of $706 million, $643 million and $1.4 billion in 2014, 2013 and 2012, respectively, which were reflected as increases to common stock. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,123 | Apple Inc. | 2014 Form 10-K | 64
As of September 27, 2014 and September 28, 2013, the significant components of the Company’s deferred tax assets and liabilities were (in millions):
Deferred tax assets and liabilities reflect the effects of tax losses, credits and the future income tax effects of temporary differences ... | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,124 | Uncertain Tax Positions
Tax positions are evaluated in a two-step process. | 0001193125-14-383437/full-submission.txt |
0000320193 | 20141027 | 10-K | 1,125 | The Company first determines whether it is more likely than not that a tax position will be sustained upon examination. | 0001193125-14-383437/full-submission.txt |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.